Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies Clinical Trial
Research results from University of New Mexico, Department of Pediatrics update understanding of allergies clinical trial
July 10th, 2007
Research findings, "Levalbuterol for asthma: a better treatment," are discussed in a new report. According to a study from the United States, "The purpose of this review is to determine whether the proinflammatory actions identified in vitro for (S)-albuterol provide a clinically significant therapeutic advantage for levalbuterol over racemic albuterol. Clinical trials evaluating the bronchodilation in chronic and acute asthma provide conflicting evidence." "Older trials suggested an advantage for levalbuterol; however, the newer trials have failed to confirm those advantages. Although (S)-albuterol produces increased bronchial hyperresponsiveness in vitro and in animal...
Source: Drug Law Weekly (2007-07-10)
|
